Loading organizations...
Key people at SUZUKEN.
SUZUKEN CO., LTD. develops and markets ethical pharmaceuticals, diagnostic reagents, medical equipment, and specialized medical foods. Their integrated operations cover pharmaceutical distribution, product development, and extensive support for community healthcare and nursing care. The company strategically delivers diverse healthcare solutions to cultivate a robust health creation ecosystem.
Established November 13, 1932, and incorporated August 10, 1964, SUZUKEN began with a mission to generate societal value. Its foundational principles derive from Yoshiki Bessho’s management philosophy, which prioritized customer-centric learning and an innovative vision. This early insight propelled the company's enduring commitment to comprehensive "health creation."
SUZUKEN primarily serves medical and healthcare professionals, including hospitals, clinics, and pharmacies, benefiting patients and caregivers. The company’s vision is to be a dedicated "health creator," tirelessly working to enhance global health and improve lives. They achieve this by innovating across the entire healthcare landscape, providing lasting value for future generations.
SUZUKEN has 1 tracked investment across 1 company. The latest tracked deal is $26.2M Series C in Ubie in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 22, 2022 | Ubie | $26.2M Series C | — | DAI Ichi Life, EGG FORWARD, Norinchukin Capital, Venture Capital Limited |
Key people at SUZUKEN.